by journal – Page 249 – Retraction Watch

Researcher who threatened Retraction Watch with lawsuit corrects funding source for several papers

Ariel Fernandez, an Argentine chemist (who claims to hold the fastest-awarded PhD from Yale) and the subject of institutional investigations at multiple universities, has corrected several papers recently. What makes the moves particularly unusual — and interesting — is the stated reason for the amendments: disclaiming any funding from the National Institutes of Health for the work.

Fernandez was the recipient in 2005 of a $275,880 award “Protein packing defects as functional markers and drug targets.” The following year he received $294,217, and in 2007, $284,461, for the same four-year project, if we’re reading the link correctly.

Fernandez, readers of this blog might recall, threatened us with legal action when we wrote last spring about an expression of concern regarding his 2011 paper in BMC Genomics, “Subfunctionalization reduces the fitness cost of gene duplication in humans by buffering dosage imbalances.” According to that notice: Continue reading Researcher who threatened Retraction Watch with lawsuit corrects funding source for several papers

Plant journal withdraws paper — or does it?

The temporary withdrawal of a Molecular Plant paper had us scratching our heads, but the issue seems to be explained by a glitch.

If you click on this version of “Application of the CRISPR–Cas System for Efficient Genome Engineering in Plants” (subscription required), you see this:

This paper has been withdrawn pending a decision by the Editorial Board

But that page also says that the latest version of the paper was published on October 3. Clicking on that version sends you to the paper, which begins: Continue reading Plant journal withdraws paper — or does it?

Stem cell scientist says data in retracted paper “is not falsified or fabricated”

Feuer_detail — Gerold Feuer, via Upstate

On Wednesday, we brought you the story of a retraction by Gerold Feuer, a State University of New York (SUNY) Upstate Medical Center stem cell scientist whom the university had found to have misused grants. He was suspended, but successfully fought that action. We had asked Feuer for comment at that time, and he has now responded:

SUNY Upstate Medical University’s decision to widely publicize the recent decision by the journal Stem Cells to retract an article from my laboratory is a vindictive and retaliatory campaign to defame my scientific credentials in the press and to my scientific colleagues.

I unequivocally state that the data in all published manuscripts is valid and sound and is not falsified or fabricated. SUNY UMU unilaterally requested a retraction from Stem Cells, despite the fact that the federal Office of Research Integrity (ORI) has not yet ruled on these allegations. It is not surprising that UMU has decided to publicize this retraction in a public forum as a second attempt to force me from my tenured faculty position and circumvent decision of the employment arbitrator and the New York Supreme Court.

To date SUNY UMU has refused to abide by the arbitrator’s “binding” decision to reinstate my faculty position and has failed to pay proper back-wages. The arbitrator evaluated operations of my spin-off company, Humurine Technologies, and stated: Continue reading Stem cell scientist says data in retracted paper “is not falsified or fabricated”

Say “Argh!” Dental journal extracts paper for plagiarism

A group of authors from Saudi Arabia and Egypt has lost their 2012 paper in the International Journal of Dentistry for what appears to be a case of large-scale lifting of text from a previously published paper.

The now-retracted article was titled “A Prospective Study of Early Loaded Single Implant-Retained Mandibular Overdentures: Preliminary One-Year Results,” and has yet to be cited, according to Thomson Scientific’s Web of Knowledge.

From the abstract: Continue reading Say “Argh!” Dental journal extracts paper for plagiarism

Pamela Ronald does the right thing again, retracting a Science paper

About a month ago, we reported on a retraction by Pamela Ronald, of the University of California, Davis, and colleagues. We noted then that this was a case of scientists doing the right thing. Ronald contacted us after that post ran, and let us know that there would be another retraction shortly. That retraction notice has now appeared, in Science: Continue reading Pamela Ronald does the right thing again, retracting a Science paper

Embryonic stem cell paper retracted for fabrication

Stem Cells and Development has retracted a paper it published earlier this year after the leader of the study reported that the data were unreliable.

The paper, “Derivation and Genetic Modification of Embryonic Stem Cells from Disease-Model Inbred Rat Strains,” came from the lab of Aron Geurts, of the Medical College of Wisconsin.

According to the retraction notice: Continue reading Embryonic stem cell paper retracted for fabrication

Retraction appears for stem cell researcher found to have used funds for his company’s gain

A stem cell journal is retracting a paper by Gerold Feuer, a researcher at the State University of New York (SUNY) Upstate Medical Center in Syracuse who was also found to have misused grants.

The Feuer story is complicated. Heralded in 2008 for landing $6.2 million in grants from the New York Stem Cell Board, Feuer was suspended in October 2010 while the university investigated allegations he had misused funds, specifically to funnel state dollars to HuMurine, a company he founded in 2008. In December 2010, Upstate said they had found evidence he had committed 53 acts of financial misconduct, and dismissed him.

From an August 2012 court ruling on a case Feuer brought to fight that dismissal: Continue reading Retraction appears for stem cell researcher found to have used funds for his company’s gain

Aoki notches fourth retraction for image problems

We have a fourth retraction in the Journal of Biochemistry for Naohito Aoki, a Japanese researcher and former postdoc in a German lab, whose images have been called into question but whose retraction notices were scant. In this case, however, the journal, while not exactly overbrimming with information about the article, at least gives us some sense of what’s going on.

Aoki worked in the lab of Axel Ullrich, of the Max Planck Institute of Biochemistry, and appeared on two retracted articles in the Journal of Biological Chemistry (JBC) with his mentor, along with a third with a co-author from Japan, Tsukasa Matsuda. Although those notices don’t say anything about the reason for the retractions — this was before the JBC started providing such information — Ulrich told us that Aoki had been manipulating images. Continue reading Aoki notches fourth retraction for image problems

Second retraction for chemist from Portugal who forged names, data

Chemical Engineering Journal has retracted a 2011 article from a group of researchers in Portugal after determining that the scientists made up their data.

The clincher: According to the journal, the researchers did not possess the proper lab equipment to perform the study as reported.

The article, “Detoxification of high-strength liquid pollutants in an ozone bubble column reactor: Gas–liquid flow patterns, interphase mass transfer and chemical depuration,” appeared in August 2011 and was written by Rodrigo J. G. Lopes and Rosa M. Quinta-Ferreira, from the Group on Environmental, Reaction and Separation Engineering in the Department of Chemical Engineering at the University of Coimbra. The paper has been cited twice, according to Thomson Scientific’s Web of Knowledge, both times by the original authors.

Here’s what the abstract has to say about the work: Continue reading Second retraction for chemist from Portugal who forged names, data